0001493152-22-023373.txt : 20220817 0001493152-22-023373.hdr.sgml : 20220817 20220817201536 ACCESSION NUMBER: 0001493152-22-023373 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220815 FILED AS OF DATE: 20220817 DATE AS OF CHANGE: 20220817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arno Andrew CENTRAL INDEX KEY: 0001472122 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37648 FILM NUMBER: 221176031 MAIL ADDRESS: STREET 1: C/O MERRIMAN CURHAN FORD GROUP, INC. STREET 2: 600 CALIFORNIA STREET, 9TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncocyte Corp CENTRAL INDEX KEY: 0001642380 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 271041563 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15 CUSHING CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-409-7600 MAIL ADDRESS: STREET 1: 15 CUSHING CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: OncoCyte Corp DATE OF NAME CHANGE: 20200213 FORMER COMPANY: FORMER CONFORMED NAME: Oncocyte Corp DATE OF NAME CHANGE: 20200205 FORMER COMPANY: FORMER CONFORMED NAME: OncoCyte Corp DATE OF NAME CHANGE: 20150513 4 1 ownership.xml X0306 4 2022-08-15 0 0001642380 Oncocyte Corp OCX 0001472122 Arno Andrew C/O ONCOCYTE CORPORATION 15 CUSHING IRVINE CA 92618 1 0 0 0 Common Stock, no par value 2022-08-15 4 A 0 10000 0 A 132049 D Common Stock, no par value 2022-08-15 4 P 0 34477 0.93 A 166526 D Common Stock, no par value 2022-08-16 4 P 0 115523 0.97 A 282049 D Option to Purchase Common Stock 0.97 2022-08-15 4 A 0 45000 0 A 2032-08-15 Common Stock 45000 45000 D The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders. The price of $0.93 per share represents a weighted average of prices ranging from $0.90 to $0.95 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price of $0.97 per share represents a weighted average of prices ranging from $0.93 to $1.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders. /s/ Andrew Arno 2022-08-17